we 201 has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igarashi, J; Ishihara, Y; Kohno, M; Kosaka, H; Kubota, Y; Moriue, T; Nakai, K; Ohmori, K; Yoneda, K | 1 |
| Higuchi, S; Ichikawa, K; Iida, M; Iino, K; Iwase, M; Ohdo, S; Sonoki, K; Yoshinari, M | 1 |
| Hattori, H; Higuchi, S; Iida, M; Iwase, M; Ohdo, S; Sasaki, N; Sonoki, K | 1 |
3 other study(ies) available for we 201 and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Lipid peroxidation-induced VEGF expression in the skin of KKAy obese mice.
Topics: Animals; Antibodies; CD36 Antigens; Cell Line; Cell Proliferation; Diabetes Mellitus, Type 2; Disease Models, Animal; Epidermis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratinocytes; Lipid Peroxidation; Lipoproteins, LDL; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Mice, Obese; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Quinolines; Skin; Thiobarbituric Acid Reactive Substances; Vascular Endothelial Growth Factor A | 2011 |
Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor.
Topics: Arteriosclerosis; Chemokine CCL2; Diabetes Mellitus, Type 2; DNA; Endothelium, Vascular; Gene Expression; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; NF-kappa B; Nitric Oxide Donors; Nitro Compounds; Phospholipases A; Phospholipases A2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Umbilical Veins | 2003 |
Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; Simvastatin | 2008 |